Interpreting drug synergy in breast cancer with deep learning using target-protein inhibition profiles

Breast cancer is the most common malignancy among women worldwide. Despite advances in treating breast cancer over the past decades, drug resistance and adverse effects remain challenging. Recent therapeutic p...

Source: BioData Mining - February 29, 2024 Category: Bioinformatics Authors: Thanyawee Srithanyarat, Kittisak Taoma, Thana Sutthibutpong, Marasri Ruengjitchatchawalya, Monrudee Liangruksa and Teeraphan Laomettachit Tags: Research Source Type: research